Strong Results and Pipeline Momentum Power Amgen’s (AMGN) 2025 Rally

Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Strong Results and Pipeline Momentum Power Amgen’s (AMGN) 2025 Rally Amgen Inc. (NASDAQ:AMGN) has outperformed the broader market this year, supported by strong financial results and steady clinical progress, even as investors keep an eye on upcoming patent expirations. The stock is up more than 27% since the start of 2025. In the third quarter, revenue rose 12% from a year earlier to $9.6 billion. Several of t ...